Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Originally published in Science Express on 16 February 2006
Science 31 March 2006:
Vol. 311. no. 5769, pp. 1924 - 1927
DOI: 10.1126/science.1122927
Prev | Table of Contents | Next

Reports

Selective Stimulation of T Cell Subsets with Antibody-Cytokine Immune Complexes

Onur Boyman,1 Marek Kovar,1 Mark P. Rubinstein,1 Charles D. Surh,1 Jonathan Sprent1,2*

Interleukin-2 (IL-2), which is a growth factor for T lymphocytes, can also sometimes be inhibitory. Thus, the proliferation of CD8+ T cells in vivo is increased after the injection of a monoclonal antibody that is specific for IL-2 (IL-2 mAb), perhaps reflecting the removal of IL-2–dependent CD4+ T regulatory cells (T regs). Instead, we show here that IL-2 mAb augments the proliferation of CD8+ cells in mice simply by increasing the biological activity of preexisting IL-2 through the formation of immune complexes. When coupled with recombinant IL-2, some IL-2/IL-2 mAb complexes cause massive (>100-fold) expansion of CD8+ cells in vivo, whereas others selectively stimulate CD4+ T regs. Thus, different cytokine-antibody complexes can be used to selectively boost or inhibit the immune response.

1 Department of Immunology, IMM4, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
2 Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, NSW 2010, Australia.

* To whom correspondence should be addressed. E-mail: j.sprent{at}garvan.org.au

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Loss of parity between IL-2 and IL-21 in the NOD Idd3 locus.
H. M. McGuire, A. Vogelzang, N. Hill, M. Flodstrom-Tullberg, J. Sprent, and C. King (2009)
PNAS 106, 19438-19443
   Abstract »    Full Text »    PDF »
In Vivo Expansion of Activated Naive CD8+ T Cells and NK Cells Driven by Complexes of IL-2 and Anti-IL-2 Monoclonal Antibody As Novel Approach of Cancer Immunotherapy.
J. Tomala, H. Chmelova, T. Mrkvan, B. Rihova, and M. Kovar (2009)
J. Immunol. 183, 4904-4912
   Abstract »    Full Text »    PDF »
Targeting NF-{kappa}B with a Natural Triterpenoid Alleviates Skin Inflammation in a Mouse Model of Psoriasis.
H. Wang, T. Syrovets, D. Kess, B. Buchele, H. Hainzl, O. Lunov, J. M. Weiss, K. Scharffetter-Kochanek, and T. Simmet (2009)
J. Immunol. 183, 4755-4763
   Abstract »    Full Text »    PDF »
Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?.
L. R. Guerin, J. R. Prins, and S. A. Robertson (2009)
Hum. Reprod. Update 15, 517-535
   Abstract »    Full Text »    PDF »
Tissue-Specific Abundance of Regulatory T Cells Correlates with CD8+ T Cell Dysfunction and Chronic Retrovirus Loads.
L. Myers, R. J. Messer, A. B. Carmody, and K. J. Hasenkrug (2009)
J. Immunol. 183, 1636-1643
   Abstract »    Full Text »    PDF »
The Initial Phase of an Immune Response Functions to Activate Regulatory T Cells.
W. E. O'Gorman, H. Dooms, S. H. Thorne, W. F. Kuswanto, E. F. Simonds, P. O. Krutzik, G. P. Nolan, and A. K. Abbas (2009)
J. Immunol. 183, 332-339
   Abstract »    Full Text »    PDF »
Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment.
L. K. Swee, N. Bosco, B. Malissen, R. Ceredig, and A. Rolink (2009)
Blood 113, 6277-6287
   Abstract »    Full Text »    PDF »
PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo.
S. Chikuma, S. Terawaki, T. Hayashi, R. Nabeshima, T. Yoshida, S. Shibayama, T. Okazaki, and T. Honjo (2009)
J. Immunol. 182, 6682-6689
   Abstract »    Full Text »    PDF »
CARMA1 Controls an Early Checkpoint in the Thymic Development of FoxP3+ Regulatory T Cells.
L. L. Molinero, J. Yang, T. Gajewski, C. Abraham, M. A. Farrar, and M.-L. Alegre (2009)
J. Immunol. 182, 6736-6743
   Abstract »    Full Text »    PDF »
Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice.
J. A. Emamaullee, J. Davis, S. Merani, C. Toso, J. F. Elliott, A. Thiesen, and A.M. J. Shapiro (2009)
Diabetes 58, 1302-1311
   Abstract »    Full Text »    PDF »
RANK-RANKL Signaling Pathway Is Critically Involved in the Function of CD4+CD25+ Regulatory T Cells in Chronic Colitis.
T. Totsuka, T. Kanai, Y. Nemoto, T. Tomita, R. Okamoto, K. Tsuchiya, T. Nakamura, N. Sakamoto, H. Akiba, K. Okumura, et al. (2009)
J. Immunol. 182, 6079-6087
   Abstract »    Full Text »    PDF »
Cutting Edge: IL-2 Immune Complexes As a Therapy for Persistent Virus Infection.
M. J. Molloy, W. Zhang, and E. J. Usherwood (2009)
J. Immunol. 182, 4512-4515
   Abstract »    Full Text »    PDF »
In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression.
K. E. Webster, S. Walters, R. E. Kohler, T. Mrkvan, O. Boyman, C. D. Surh, S. T. Grey, and J. Sprent (2009)
J. Exp. Med. 206, 751-760
   Abstract »    Full Text »    PDF »
Recall Responses by Helpless Memory CD8+ T Cells Are Restricted by the Up-Regulation of PD-1.
S. Fuse, C.-Y. Tsai, M. J. Molloy, S. R. Allie, W. Zhang, H. Yagita, and E. J. Usherwood (2009)
J. Immunol. 182, 4244-4254
   Abstract »    Full Text »    PDF »
Endogenously Produced IL-4 Nonredundantly Stimulates CD8+ T Cell Proliferation.
S. C. Morris, S. M. Heidorn, D. R. Herbert, C. Perkins, D. A. Hildeman, M. V. Khodoun, and F. D. Finkelman (2009)
J. Immunol. 182, 1429-1438
   Abstract »    Full Text »    PDF »
Overcoming Immunoescape Mechanisms of BCL1 Leukemia and Induction of CD8+ T-Cell-Mediated BCL1-Specific Resistance in Mice Cured by Targeted Polymer-Bound Doxorubicin.
M. Kovar, J. Tomala, H. Chmelova, L. Kovar, T. Mrkvan, R. Joskova, Z. Zakostelska, T. Etrych, J. Strohalm, K. Ulbrich, et al. (2008)
Cancer Res. 68, 9875-9883
   Abstract »    Full Text »    PDF »
Suppression of Murine Allergic Airway Disease by IL-2:Anti-IL-2 Monoclonal Antibody-Induced Regulatory T Cells.
M. S. Wilson, J. T. Pesce, T. R. Ramalingam, R. W. Thompson, A. Cheever, and T. A. Wynn (2008)
J. Immunol. 181, 6942-6954
   Abstract »    Full Text »    PDF »
IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response.
M. P. Rubinstein, N. A. Lind, J. F. Purton, P. Filippou, J. A. Best, P. A. McGhee, C. D. Surh, and A. W. Goldrath (2008)
Blood 112, 3704-3712
   Abstract »    Full Text »    PDF »
Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy.
G. Verdeil, K. Marquardt, C. D. Surh, and L. A. Sherman (2008)
PNAS 105, 16683-16688
   Abstract »    Full Text »    PDF »
Endoplasmic Reticulum Stress Regulator XBP-1 Contributes to Effector CD8+ T Cell Differentiation during Acute Infection.
D. Kamimura and M. J. Bevan (2008)
J. Immunol. 181, 5433-5441
   Abstract »    Full Text »    PDF »
PILAR is a novel modulator of human T-cell expansion.
E. Huarte, J. R. Cubillos-Ruiz, Y. C. Nesbeth, U. K. Scarlett, D. G. Martinez, X. A. Engle, W. F. Rigby, P. A. Pioli, P. M. Guyre, and J. R. Conejo-Garcia (2008)
Blood 112, 1259-1268
   Abstract »    Full Text »    PDF »
T-cell Development and Function Are Modulated by Dual Specificity Phosphatase DUSP5.
P. E. Kovanen, J. Bernard, A. Al-Shami, C. Liu, J. Bollenbacher-Reilley, L. Young, C. Pise-Masison, R. Spolski, and W. J. Leonard (2008)
J. Biol. Chem. 283, 17362-17369
   Abstract »    Full Text »    PDF »
Interleukin-13 Neutralization by Two Distinct Receptor Blocking Mechanisms Reduces Immunoglobulin E Responses and Lung Inflammation in Cynomolgus Monkeys.
M. T. Kasaian, X.-Y. Tan, M. Jin, L. Fitz, K. Marquette, N. Wood, T. A. Cook, J. Lee, A. Widom, R. Agostinelli, et al. (2008)
J. Pharmacol. Exp. Ther. 325, 882-892
   Abstract »    Full Text »    PDF »
Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation.
G.-H. Jin, T. Hirano, and M. Murakami (2008)
Int. Immunol. 20, 783-789
   Abstract »    Full Text »    PDF »
IL-7/Anti-IL-7 mAb Complexes Restore T Cell Development and Induce Homeostatic T Cell Expansion without Lymphopenia.
O. Boyman, C. Ramsey, D. M. Kim, J. Sprent, and C. D. Surh (2008)
J. Immunol. 180, 7265-7275
   Abstract »    Full Text »    PDF »
Radiolabeled and Native Antibodies and the Prospect of Cure of Follicular Lymphoma.
F. Buchegger, O. W. Press, A. B. Delaloye, and N. Ketterer (2008)
Oncologist 13, 657-667
   Abstract »    Full Text »    PDF »
IL-15R{alpha} chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation.
E. Mortier, T. Woo, R. Advincula, S. Gozalo, and A. Ma (2008)
J. Exp. Med. 205, 1213-1225
   Abstract »    Full Text »    PDF »
Cutting Edge: Enhanced IL-2 Signaling Can Convert Self-Specific T Cell Response from Tolerance to Autoimmunity.
J. Waithman, T. Gebhardt, G. M. Davey, W. R. Heath, and F. R. Carbone (2008)
J. Immunol. 180, 5789-5793
   Abstract »    Full Text »    PDF »
IL-2/Anti-IL-2 Antibody Complex Enhances Vaccine-Mediated Antigen-Specific CD8+ T Cell Responses and Increases the Ratio of Effector/Memory CD8+ T Cells to Regulatory T Cells.
S. Mostbock, M. E. C. Lutsiak, D. E. Milenic, K. Baidoo, J. Schlom, and H. Sabzevari (2008)
J. Immunol. 180, 5118-5129
   Abstract »    Full Text »    PDF »
Preassociation of IL-15 with IL-15R{alpha}-IgG1-Fc Enhances Its Activity on Proliferation of NK and CD8+/CD44high T Cells and Its Antitumor Action.
S. Dubois, H. J. Patel, M. Zhang, T. A. Waldmann, and J. R. Muller (2008)
J. Immunol. 180, 2099-2106
   Abstract »    Full Text »    PDF »
Kinetic and Mechanistic Requirements for Helping CD8 T Cells.
P. Agnellini, M. Wiesel, K. Schwarz, P. Wolint, M. F. Bachmann, and A. Oxenius (2008)
J. Immunol. 180, 1517-1525
   Abstract »    Full Text »    PDF »
Control of Memory CD8+ T Cell Differentiation by CD80/CD86-CD28 Costimulation and Restoration by IL-2 during the Recall Response.
S. Fuse, W. Zhang, and E. J. Usherwood (2008)
J. Immunol. 180, 1148-1157
   Abstract »    Full Text »    PDF »
Cutting Edge: Mechanism of Enhancement of In Vivo Cytokine Effects by Anti-Cytokine Monoclonal Antibodies.
J. D. Phelan, T. Orekov, and F. D. Finkelman (2008)
J. Immunol. 180, 44-48
   Abstract »    Full Text »    PDF »
Rapid generation of a functional NK-cell compartment.
M. Prlic, D. Kamimura, and M. J. Bevan (2007)
Blood 110, 2024-2026
   Abstract »    Full Text »    PDF »
Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo.
D. Kamimura and M. J. Bevan (2007)
J. Exp. Med. 204, 1803-1812
   Abstract »    Full Text »    PDF »
An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2.
J.-H. Cho, O. Boyman, H.-O. Kim, B. Hahm, M. P. Rubinstein, C. Ramsey, D. M. Kim, C. D. Surh, and J. Sprent (2007)
J. Exp. Med. 204, 1787-1801
   Abstract »    Full Text »    PDF »
Frontiers in Nephrology: T Cell Memory as a Barrier to Transplant Tolerance.
A. Valujskikh and X. C. Li (2007)
J. Am. Soc. Nephrol. 18, 2252-2261
   Full Text »    PDF »
OX40-Mediated Differentiation to Effector Function Requires IL-2 Receptor Signaling but Not CD28, CD40, IL-12Rbeta2, or T-bet.
C. A. Williams, S. E. Murray, A. D. Weinberg, and D. C. Parker (2007)
J. Immunol. 178, 7694-7702
   Abstract »    Full Text »    PDF »
Neutralizing antibodies to interferon.
A. Noronha (2007)
Neurology 68, S16-S22
   Abstract »    Full Text »    PDF »
Cutting Edge: A Regulatory T Cell-Dependent Novel Function of CD25 (IL-2R{alpha}) Controlling Memory CD8+ T Cell Homeostasis.
R. Sharma, L. Zheng, U. S. Deshmukh, W. N. Jarjour, S.-s. J. Sung, S. M. Fu, and S.-T. Ju (2007)
J. Immunol. 178, 1251-1255
   Abstract »    Full Text »    PDF »
Latent Virus Influences the Generation and Maintenance of CD8+ T Cell Memory.
B. S. Sheridan, K. M. Khanna, G. M. Frank, and R. L. Hendricks (2006)
J. Immunol. 177, 8356-8364
   Abstract »    Full Text »    PDF »
Time to restore individual rights for IL-2 and IL-15?.
Y. Tagaya (2006)
Blood 108, 409-410
   Full Text »    PDF »
A major histocompatibility complex class I-dependent subset of memory phenotype CD8+ cells.
O. Boyman, J.-H. Cho, J. T. Tan, C. D. Surh, and J. Sprent (2006)
J. Exp. Med. 203, 1817-1825
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)